REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$6.66
+6.05%
Mkt Cap $314.32M
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
Implied Upside
+237.8%
Consensus $22.50 vs current $6.66
NASDAQ·Healthcare·Biotechnology
$6.66
+6.05%
Mkt Cap $314.32M
Buy
11
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
+237.8%
Consensus $22.50 vs current $6.66